These differences of BCR/ABL1 driven disease in different lineages might suggest a separate cell of origin for B cell and myeloid disease, however using purified HSCs as donor cells suggests both CML and B ALL can arise from a long-term HSC cell of origin (170). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.